Skip to main content
Top
Published in: Heart and Vessels 7/2016

01-07-2016 | Case Report

Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks

Authors: Minoru Tagawa, Sachie Ochiai, Yuichi Nakamura, Akinori Sato, Masaomi Chinushi

Published in: Heart and Vessels | Issue 7/2016

Login to get access

Abstract

A 73-year-old woman first visited our emergency room with multiple syncopal attacks. Before admission, she had received an antibiotic (Garenoxacin) for 3 days from a local clinic. First electrocardiogram (ECG) showed no ST-segment deviation but mild QT interval prolongation with a positive U wave. Second ECG recording 3 h later showed slightly slower heart rate and revealed marked QTU interval prolongation suggesting the cause of her syncopal attacks. After cessation of Garenoxacin, the QTU interval prolongation shortened. However, both epinephrine infusion and treadmill exercise test reproduced similar QTU interval prolongation and T wave deformities. Later, genetic analysis demonstrated that this patient had a mutation in KCNH2 gene, and she was diagnosed as a type-2 long-QT syndrome which was accentuated by use of garenoxacin. At the emergency out-patient clinic, repetitive ECG recordings can be useful and should be considered in order to identify the cause of syncopal attacks in patients who were prescribed antibiotics and had mild QT interval abnormalities.
Literature
1.
go back to reference Brignole M, Hamdan MH (2012) New concepts in the assessment of syncope. J Am Coll Cardiol 59:1583–1591CrossRefPubMed Brignole M, Hamdan MH (2012) New concepts in the assessment of syncope. J Am Coll Cardiol 59:1583–1591CrossRefPubMed
2.
go back to reference Task force for the diagnosis and management of syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), Heart Rhythm Society (HRS), Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W (2009) Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 30:2631–2671CrossRef Task force for the diagnosis and management of syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), Heart Rhythm Society (HRS), Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W (2009) Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 30:2631–2671CrossRef
4.
go back to reference Schwartz PJ, Ackerman MJ (2013) The long-QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J 34:3109–3116CrossRefPubMed Schwartz PJ, Ackerman MJ (2013) The long-QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J 34:3109–3116CrossRefPubMed
5.
go back to reference Bando S, Soeki T, Matsuura T, Niki T, Ise T, Yamaguchi K, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Akaike M, Aiba T, Shimizu W, Sata M (2014) Congenital long-QT syndrome with compound mutations in the KCNH2 gene. Heart Vessels 29(4):554–559CrossRefPubMed Bando S, Soeki T, Matsuura T, Niki T, Ise T, Yamaguchi K, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Akaike M, Aiba T, Shimizu W, Sata M (2014) Congenital long-QT syndrome with compound mutations in the KCNH2 gene. Heart Vessels 29(4):554–559CrossRefPubMed
6.
go back to reference Ayad RF, Assar MD, Simpson L, Garner JB, Schussler JM (2010) Causes and management of drug-induced long-QT syndrome. Proc (Bayl Univ Med Cent) 23:250–255 Ayad RF, Assar MD, Simpson L, Garner JB, Schussler JM (2010) Causes and management of drug-induced long-QT syndrome. Proc (Bayl Univ Med Cent) 23:250–255
8.
go back to reference Sesti F, Abbott GW, Wei J, Murray KT, Saksena S, Schwartz PJ, Priori SG, Roden DM, George AL Jr, Goldstein SA (2000) A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A 97(19):10613–10618CrossRefPubMedPubMedCentral Sesti F, Abbott GW, Wei J, Murray KT, Saksena S, Schwartz PJ, Priori SG, Roden DM, George AL Jr, Goldstein SA (2000) A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A 97(19):10613–10618CrossRefPubMedPubMedCentral
9.
go back to reference Anderson ME, Mazur A, Yang T, Roden DM (2001) Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics. J Pharmacol Exp Ther 296(3):806–810PubMed Anderson ME, Mazur A, Yang T, Roden DM (2001) Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics. J Pharmacol Exp Ther 296(3):806–810PubMed
10.
go back to reference Alexandrou AJ, Duncan RS, Sullivan A, Hancox JC, Leishman DJ, Witchel HJ, Leaney JL (2006) Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotics moxifloxacin. Br J Pharmacol 147:905–916CrossRefPubMedPubMedCentral Alexandrou AJ, Duncan RS, Sullivan A, Hancox JC, Leishman DJ, Witchel HJ, Leaney JL (2006) Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotics moxifloxacin. Br J Pharmacol 147:905–916CrossRefPubMedPubMedCentral
11.
go back to reference Gajjar DA, Bello A, Ge Z, Christopher L, Grasela DM (2003) Multiple-dose safety and pharmacokinetic of oral garenoxacin in healthy subjects. Antimicrob Agents Chemother 47(7):2256–2263CrossRefPubMedPubMedCentral Gajjar DA, Bello A, Ge Z, Christopher L, Grasela DM (2003) Multiple-dose safety and pharmacokinetic of oral garenoxacin in healthy subjects. Antimicrob Agents Chemother 47(7):2256–2263CrossRefPubMedPubMedCentral
12.
go back to reference Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z (2002) Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105:794–799CrossRefPubMed Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z (2002) Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105:794–799CrossRefPubMed
13.
go back to reference Shimizu W, Horie M (2011) Phenotypic manifestations of mutations in genes encoding subunit of cardiac potassium channels. Circ Res 109:97–109CrossRefPubMed Shimizu W, Horie M (2011) Phenotypic manifestations of mutations in genes encoding subunit of cardiac potassium channels. Circ Res 109:97–109CrossRefPubMed
14.
go back to reference Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S (2009) Genotype-phenotype aspects of type 2 long-QT syndrome. J Am Coll Cardiol 54(22):2052–2062CrossRefPubMedPubMedCentral Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S (2009) Genotype-phenotype aspects of type 2 long-QT syndrome. J Am Coll Cardiol 54(22):2052–2062CrossRefPubMedPubMedCentral
15.
go back to reference Mihic A, Chauhan VS, Gao X, Oudit GY, Tsushima RG (2011) Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long-QT syndrome mutation. PLoS ONE 6(3):e18273CrossRefPubMedPubMedCentral Mihic A, Chauhan VS, Gao X, Oudit GY, Tsushima RG (2011) Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long-QT syndrome mutation. PLoS ONE 6(3):e18273CrossRefPubMedPubMedCentral
16.
go back to reference Liu L, Hayashi K, Kaneda T, Ino H, Fujino N, Uchiyama K, Konno T, Tsuda T, Kawashiri MA, Ueda K, Higashikata T, Shuai W, Kupershmidt S, Higashida H, Yamagishi M (2013) A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long-QT syndrome. Heart Rhythm 10(1):61–67CrossRefPubMed Liu L, Hayashi K, Kaneda T, Ino H, Fujino N, Uchiyama K, Konno T, Tsuda T, Kawashiri MA, Ueda K, Higashikata T, Shuai W, Kupershmidt S, Higashida H, Yamagishi M (2013) A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long-QT syndrome. Heart Rhythm 10(1):61–67CrossRefPubMed
17.
go back to reference Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89–95CrossRefPubMed Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89–95CrossRefPubMed
18.
go back to reference Wong JA, Gula LJ, Klein GJ, Yee R, Skanes AC, Krahn AD (2010) Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ Arrhythm Electrophysiol 3(2):120–125CrossRefPubMed Wong JA, Gula LJ, Klein GJ, Yee R, Skanes AC, Krahn AD (2010) Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ Arrhythm Electrophysiol 3(2):120–125CrossRefPubMed
19.
go back to reference Clur SA, Chockalingam P, Filippini LH, Widyanti AP, Van Cruijsen M, Blom NA, Alders M, Hofman N, Wilde AA (2010) The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long-QT syndrome. Pediatr Cardiol 31(4):462–468CrossRefPubMed Clur SA, Chockalingam P, Filippini LH, Widyanti AP, Van Cruijsen M, Blom NA, Alders M, Hofman N, Wilde AA (2010) The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long-QT syndrome. Pediatr Cardiol 31(4):462–468CrossRefPubMed
20.
21.
go back to reference Vyas H, Hejlik J, Ackerman MJ (2006) Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical response. Circulation 113(11):1385–1392CrossRefPubMed Vyas H, Hejlik J, Ackerman MJ (2006) Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical response. Circulation 113(11):1385–1392CrossRefPubMed
22.
go back to reference Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin JA, Priori SG, Kamakura S (2004) Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long-QT syndrome. Heart Rhythm 1(3):276–283CrossRefPubMed Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin JA, Priori SG, Kamakura S (2004) Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long-QT syndrome. Heart Rhythm 1(3):276–283CrossRefPubMed
23.
go back to reference Hekkala AM, Viitasalo M, Väänänen H, Swan H, Toivonen L (2010) Abnormal repolarization dynamics revealed in exercise test in long-QT syndrome mutation carriers with normal resting QT interval. Europace 12(9):1296–1301CrossRefPubMed Hekkala AM, Viitasalo M, Väänänen H, Swan H, Toivonen L (2010) Abnormal repolarization dynamics revealed in exercise test in long-QT syndrome mutation carriers with normal resting QT interval. Europace 12(9):1296–1301CrossRefPubMed
24.
go back to reference Schwartz PJ, Vanoli E, Crotti L, Spazzolini C, Ferrandi C, Goosen A, Hedley P, Heradien M, Bacchini S, Turco A, La Rovere MT, Bartoli A, George AL Jr, Brink PA (2008) Neural control of heart rate is an arrhythmia risk modifier in long-QT syndrome. J Am Coll Cardiol 51(9):920–929CrossRefPubMed Schwartz PJ, Vanoli E, Crotti L, Spazzolini C, Ferrandi C, Goosen A, Hedley P, Heradien M, Bacchini S, Turco A, La Rovere MT, Bartoli A, George AL Jr, Brink PA (2008) Neural control of heart rate is an arrhythmia risk modifier in long-QT syndrome. J Am Coll Cardiol 51(9):920–929CrossRefPubMed
25.
go back to reference Nagaoka I, Shimizu W, Mizusawa Y, Sakaguchi T, Itoh H, Ohno S, Makiyama T, Yamagata K, Makimoto H, Miyamoto Y, Kamakura S, Horie M (2010) Heart rate-dependent variability of cardiac events in type 2 congenital long-QT syndrome. Europace 12(11):1623–1629CrossRefPubMed Nagaoka I, Shimizu W, Mizusawa Y, Sakaguchi T, Itoh H, Ohno S, Makiyama T, Yamagata K, Makimoto H, Miyamoto Y, Kamakura S, Horie M (2010) Heart rate-dependent variability of cardiac events in type 2 congenital long-QT syndrome. Europace 12(11):1623–1629CrossRefPubMed
26.
go back to reference Fossa AA (2008) The impact of varying autonomic states on the dynamic beat-to-beat QT-RR and QT-TQ interval relationships. Br J Pharmacol 154(7):1508–1515CrossRefPubMedPubMedCentral Fossa AA (2008) The impact of varying autonomic states on the dynamic beat-to-beat QT-RR and QT-TQ interval relationships. Br J Pharmacol 154(7):1508–1515CrossRefPubMedPubMedCentral
27.
go back to reference Fujiki A, Yoshioka R, Sakabe M (2015) Evaluation of repolarization dynamics using the QT-RR regression line slope and intercept relationship during 24-h Holter ECG. Heart Vessels 30(2):235–240CrossRefPubMed Fujiki A, Yoshioka R, Sakabe M (2015) Evaluation of repolarization dynamics using the QT-RR regression line slope and intercept relationship during 24-h Holter ECG. Heart Vessels 30(2):235–240CrossRefPubMed
28.
go back to reference Goldenberg I, Mathew J, Moss AJ, McNitt S, Peterson DR, Zareba W, Benhorin J, Zhang L, Vincent GM, Andrews ML, Robinson JL, Morray B (2006) Corrected QT variability in serial electrocardiograms in long-QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 48(5):1047–1052CrossRefPubMed Goldenberg I, Mathew J, Moss AJ, McNitt S, Peterson DR, Zareba W, Benhorin J, Zhang L, Vincent GM, Andrews ML, Robinson JL, Morray B (2006) Corrected QT variability in serial electrocardiograms in long-QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol 48(5):1047–1052CrossRefPubMed
Metadata
Title
Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks
Authors
Minoru Tagawa
Sachie Ochiai
Yuichi Nakamura
Akinori Sato
Masaomi Chinushi
Publication date
01-07-2016
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 7/2016
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0693-x

Other articles of this Issue 7/2016

Heart and Vessels 7/2016 Go to the issue